{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:40:17Z","timestamp":1793922017719,"version":"4.8.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Ministry for Science","award":["01KI2016"],"award-info":[{"award-number":["01KI2016"]}]},{"name":"German Ministry for Science","award":["031L0176A"],"award-info":[{"award-number":["031L0176A"]}]},{"name":"Ministry of Health","award":["D81785FG17"],"award-info":[{"award-number":["D81785FG17"]}]},{"DOI":"10.13039\/501100007229","name":"special research fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Comprehensive pathogen genomic surveillance represents a powerful tool to complement and advance precision vaccinology. The emergence of the Alpha variant in December 2020 and the resulting efforts to track the spread of this and other severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern led to an expansion of genomic sequencing activities in Germany.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>At Robert Koch Institute (RKI), the German National Institute of Public Health, we established the Integrated Molecular Surveillance for SARS-CoV-2 (IMS-SC2) network to perform SARS-CoV-2 genomic surveillance at the national scale, SARS-CoV-2\u2013positive samples from laboratories distributed across Germany regularly undergo whole-genome sequencing at RKI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We report analyses of 3623 SARS-CoV-2 genomes collected between December 2020 and December 2021, of which 3282 were randomly sampled. All variants of concern were identified in the sequenced sample set, at ratios equivalent to those in the 100-fold larger German GISAID sequence dataset from the same time period. Phylogenetic analysis confirmed variant assignments. Multiple mutations of concern emerged during the observation period. To model vaccine effectiveness in vitro, we employed authentic-virus neutralization assays, confirming that both the Beta and Zeta variants are capable of immune evasion. The IMS-SC2 sequence dataset facilitated an estimate of the SARS-CoV-2 incidence based on genetic evolution rates. Together with modeled vaccine efficacies, Delta-specific incidence estimation indicated that the German vaccination campaign contributed substantially to a deceleration of the nascent German Delta wave.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>SARS-CoV-2 molecular and genomic surveillance may inform public health policies including vaccination strategies and enable a proactive approach to controlling coronavirus disease 2019 spread as the virus evolves.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac399","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T19:51:22Z","timestamp":1656100282000},"page":"S110-S120","source":"Crossref","is-referenced-by-count":27,"title":["Advancing Precision Vaccinology by Molecular and Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 in Germany, 2021"],"prefix":"10.1093","volume":"75","author":[{"given":"Djin Ye","family":"Oh","sequence":"first","affiliation":[{"name":"Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00f6lzer","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Paraskevopoulou","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trofimova","sequence":"additional","affiliation":[{"name":"Systems Medicine of Infectious Disease (P5), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hartkopf","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Budt","sequence":"additional","affiliation":[{"name":"Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Wedde","sequence":"additional","affiliation":[{"name":"Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Richard","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Haldemann","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Domaszewska","sequence":"additional","affiliation":[{"name":"Respiratory Infections (FG36), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Reiche","sequence":"additional","affiliation":[{"name":"Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Keeren","sequence":"additional","affiliation":[{"name":"Gastroenteritis and Hepatitis Pathogens and Enteroviruses (FG15), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Radoni\u0107","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Patricia","family":"Ramos Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen Rebecca","family":"Smith","sequence":"additional","affiliation":[{"name":"Systems Medicine of Infectious Disease (P5), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Brinkmann","sequence":"additional","affiliation":[{"name":"Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Trappe","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Drechsel","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Klaper","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute , Berlin , Germany"},{"name":"Sexually Transmitted Bacterial Pathogens and HIV (FG18), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Hein","sequence":"additional","affiliation":[{"name":"Division of Virology, Paul Ehrlich Institute , Langen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhardt","family":"Hildt","sequence":"additional","affiliation":[{"name":"Division of Virology, Paul Ehrlich Institute , Langen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Haas","sequence":"additional","affiliation":[{"name":"Gastroenteritis and Hepatitis Pathogens and Enteroviruses (FG15), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Calvignac-Spencer","sequence":"additional","affiliation":[{"name":"Epidemiology of Highly Pathogenic Microorganisms (P3), Viral Evolution, Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Semmler","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"D\u00fcrrwald","sequence":"additional","affiliation":[{"name":"Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Th\u00fcrmer","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Genome Sequencing and Genomic Epidemiology (MF2), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Drosten","sequence":"additional","affiliation":[{"name":"Institute of Virology, Charit\u00e9-University Medicine Berlin , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Methodology and Research Infrastructure, Bioinformatics and Systems Biology (MF1), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kr\u00f6ger","sequence":"additional","affiliation":[{"name":"Gastroenteritis and Hepatitis Pathogens and Enteroviruses (FG15), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"von Kleist","sequence":"additional","affiliation":[{"name":"Systems Medicine of Infectious Disease (P5), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Wolff","sequence":"additional","affiliation":[{"name":"Influenza and Other Respiratory Viruses (FG17), Robert Koch Institute , Berlin , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Integrated Molecular Surveillance for SARS-CoV-2 (IMS-SC2) Laboratory Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Biere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Corman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Erren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Finzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Grosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi","family":"Krumbholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Meinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schwanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Szabados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Tewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"key":"2022081503565446000_ciac399-B1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"2022081503565446000_ciac399-B2","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/infdis\/jiab075","article-title":"Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection","volume":"223","author":"Tarhini","year":"2021","journal-title":"J Infect Dis"},{"key":"2022081503565446000_ciac399-B3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.chom.2022.01.005","article-title":"SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape","volume":"30","author":"Cele","year":"2022","journal-title":"Cell Host Microbe"},{"key":"2022081503565446000_ciac399-B4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114828118","article-title":"SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus)","volume":"118","author":"Chandler","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022081503565446000_ciac399-B5","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1038\/s41467-021-23848-9","article-title":"SARS-CoV-2 infection and transmission in the North American deer mouse","volume":"12","author":"Griffin","year":"2021","journal-title":"Nat Commun"},{"key":"2022081503565446000_ciac399-B6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.abe5901","article-title":"Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans","volume":"371","author":"Oude Munnink","year":"2021","journal-title":"Science"},{"key":"2022081503565446000_ciac399-B7","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.31.474653","article-title":"The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry","author":"Peacock","year":"2022","journal-title":"bioRxiv [Preprint]. Posted online 3 January"},{"key":"2022081503565446000_ciac399-B8","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1038\/s41467-020-20097-0","article-title":"Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy","volume":"11","author":"Patterson","year":"2020","journal-title":"Nat Commun"},{"key":"2022081503565446000_ciac399-B9","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/S2213-2600(21)00328-3","article-title":"Lifting of COVID-19 restrictions in the UK and the Delta variant","volume":"9","author":"Burki","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2022081503565446000_ciac399-B10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jcm11010030","article-title":"Relative reproduction number of SARS-CoV-2 Omicron (B.1.1.529) compared with Delta variant in South Africa","volume":"11","author":"Nishiura","year":"2021","journal-title":"J Clin Med"},{"key":"2022081503565446000_ciac399-B11","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/jmv.27560","article-title":"Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark","volume":"94","author":"Ito","year":"2021","journal-title":"J Med Virol"},{"key":"2022081503565446000_ciac399-B12","doi-asserted-by":"crossref","first-page":"e2179","DOI":"10.1002\/rmv.2179","article-title":"Comparison of influenza type A and B with COVID-19: a global systematic review and meta-analysis on clinical, laboratory and radiographic findings","volume":"31","author":"Pormohammad","year":"2021","journal-title":"Rev Med Virol"},{"key":"2022081503565446000_ciac399-B13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-2600(20)30527-0","article-title":"Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study","volume":"9","author":"Piroth","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2022081503565446000_ciac399-B14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10654-020-00698-1","article-title":"Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications","volume":"35","author":"Levin","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"2022081503565446000_ciac399-B15","first-page":"e85","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"9","author":"Soriano","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2022081503565446000_ciac399-B16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.abm2052","article-title":"Nervous system consequences of COVID-19","volume":"375","author":"Spudich","year":"2022","journal-title":"Science"},{"key":"2022081503565446000_ciac399-B17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"2022081503565446000_ciac399-B18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2022081503565446000_ciac399-B19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.2021.2828","article-title":"The potential future of the COVID-19 pandemic: will SARS-CoV-2 become a recurrent seasonal infection?","volume":"325","author":"Murray","year":"2021","journal-title":"JAMA"},{"key":"2022081503565446000_ciac399-B20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-021-03792-w","article-title":"After the pandemic: perspectives on the future trajectory of COVID-19","volume":"596","author":"Telenti","year":"2021","journal-title":"Nature"},{"key":"2022081503565446000_ciac399-B21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"2022081503565446000_ciac399-B22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":"2021","journal-title":"Nature"},{"key":"2022081503565446000_ciac399-B23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma neutralization of the SARS-CoV-2 Omicron variant","volume":"386","author":"Schmidt","year":"2022","journal-title":"N Engl J Med"},{"key":"2022081503565446000_ciac399-B24","author":"Robert Koch Institute","year":"2022"},{"key":"2022081503565446000_ciac399-B25","doi-asserted-by":"crossref","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: Global initiative on sharing all influenza data\u2014from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Euro Surveill"},{"key":"2022081503565446000_ciac399-B26","doi-asserted-by":"crossref","first-page":"100112","DOI":"10.1016\/j.lanepe.2021.100112","article-title":"Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January\u2014September 2020: analysis of national surveillance data","volume":"6","author":"Oh","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2022081503565446000_ciac399-B27","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/microorganisms9071508","article-title":"Virological surveillance and molecular characterization of human parainfluenzavirus infection in children with acute respiratory illness: Germany, 2015\u20132019","volume":"9","author":"Oh","year":"2021","journal-title":"Microorganisms"},{"key":"2022081503565446000_ciac399-B28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature"},{"key":"2022081503565446000_ciac399-B29","doi-asserted-by":"crossref","first-page":"711437","DOI":"10.3389\/fgene.2021.711437","article-title":"poreCov\u2014an easy to use, fast, and robust workflow for SARS-CoV-2 genome reconstruction via Nanopore sequencing","volume":"12","author":"Brandt","year":"2021","journal-title":"Front Genet"},{"key":"2022081503565446000_ciac399-B30","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"O'Toole","year":"2021","journal-title":"Virus Evol"},{"key":"2022081503565446000_ciac399-B31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol Biol Evol"},{"key":"2022081503565446000_ciac399-B32","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol Biol Evol"},{"key":"2022081503565446000_ciac399-B33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/molbev\/msx281","article-title":"UFBoot2: improving the ultrafast bootstrap approximation","volume":"35","author":"Hoang","year":"2018","journal-title":"Mol Biol Evol"},{"key":"2022081503565446000_ciac399-B34","doi-asserted-by":"crossref","first-page":"e8584","DOI":"10.7717\/peerj.8584","article-title":"Iroki: automatic customization and visualization of phylogenetic trees","volume":"8","author":"Moore","year":"2020","journal-title":"PeerJ"},{"key":"2022081503565446000_ciac399-B35","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/bioinformatics\/btz715","article-title":"Pavian: interactive analysis of metagenomics data for microbiome studies and pathogen identification","volume":"36","author":"Breitwieser","year":"2020","journal-title":"Bioinformatics"},{"key":"2022081503565446000_ciac399-B36","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: an R package for the visualization of intersecting sets and their properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics"},{"key":"2022081503565446000_ciac399-B37","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/v13081491","article-title":"Rise and fall of SARS-CoV-2 lineage A.27 in Germany","volume":"13","author":"Calvignac-Spencer","year":"2021","journal-title":"Viruses"},{"key":"2022081503565446000_ciac399-B38","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1038\/s41467-021-26267-y","article-title":"Rapid incidence estimation from SARS-CoV-2 genomes reveals decreased case detection in Europe during summer 2020","volume":"12","author":"Smith","year":"2021","journal-title":"Nat Commun"},{"key":"2022081503565446000_ciac399-B39","article-title":"Guidance for representative and targeted genomic SARS-CoV-2 monitoring\u20143 May 2021","author":"European Centre for Disease Prevention and Control","year":"2021"},{"key":"2022081503565446000_ciac399-B40","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bib\/bbaa232","article-title":"Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research","volume":"22","author":"Hufsky","year":"2021","journal-title":"Brief Bioinform"},{"key":"2022081503565446000_ciac399-B41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-021-03677-y","article-title":"Spread of a SARS-CoV-2 variant through Europe in the summer of 2020","volume":"595","author":"Hodcroft","year":"2021","journal-title":"Nature"},{"key":"2022081503565446000_ciac399-B42","doi-asserted-by":"publisher","DOI":"10.1111\/all.15189","article-title":"Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses [manuscript published online ahead of print 25 November 2021]","author":"Hein","year":"2021","journal-title":"Allergy"},{"key":"2022081503565446000_ciac399-B43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"2022081503565446000_ciac399-B44","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.28.21268491","article-title":"Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants","author":"Bekliz","year":"2022","journal-title":"medRxiv [Preprint]. Posted online"},{"key":"2022081503565446000_ciac399-B45","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41591-021-01472-w","article-title":"The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology","volume":"27","author":"Oude Munnink","year":"2021","journal-title":"Nat Med"},{"key":"2022081503565446000_ciac399-B46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103272118","article-title":"Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys","volume":"118","author":"Irons","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022081503565446000_ciac399-B47","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/bimj.202100125","article-title":"A statistical model for the dynamics of COVID-19 infections and their case detection ratio in 2020","volume":"63","author":"Schneble","year":"2021","journal-title":"Biom J"},{"key":"2022081503565446000_ciac399-B48","first-page":"149","article-title":"A public health antibody screening indicates a 6-fold higher SARS-CoV-2 exposure rate than reported cases in children","volume":"2","author":"Hippich","year":"2021","journal-title":"Med (N Y)"},{"key":"2022081503565446000_ciac399-B49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.15585\/mmwr.mm7023a3","article-title":"Genomic surveillance for SARS-CoV-2 variants circulating in the United States, December 2020\u2013May 2021","volume":"70","author":"Paul","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022081503565446000_ciac399-B50","doi-asserted-by":"crossref","first-page":"768883","DOI":"10.3389\/fcimb.2021.768883","article-title":"One year of SARS-CoV-2: genomic characterization of COVID-19 outbreak in Qatar","volume":"11","author":"Benslimane","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2022081503565446000_ciac399-B51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13059-021-02395-y","article-title":"CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance","volume":"22","author":"Nicholls","year":"2021","journal-title":"Genome Biol"},{"key":"2022081503565446000_ciac399-B52","doi-asserted-by":"crossref","first-page":"e481\u20134","DOI":"10.1016\/S2666-5247(21)00121-X","article-title":"Genomic surveillance to combat COVID-19: challenges and opportunities","volume":"2","author":"Robishaw","year":"2021","journal-title":"Lancet Microbe"},{"key":"2022081503565446000_ciac399-B53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"2022081503565446000_ciac399-B54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2021","journal-title":"Cell"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac399\/44253851\/ciac399.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_1\/S110\/45407488\/ciac399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_1\/S110\/45407488\/ciac399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T03:57:45Z","timestamp":1660535865000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/Supplement_1\/S110\/6617635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":54,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2022,6,25]]},"published-print":{"date-parts":[[2022,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac399","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,15]]},"published":{"date-parts":[[2022,6,25]]}}}